Neoplasms, Anal
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064) (NCT04635423) | Merck Sharp & Dohme LLC | 2020-11-30 |
Track Neoplasms, Anal automatically
Every clearance here is in the API, with alerts when new ones post.